These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1649715)

  • 21. Sulphonylurea stimulates glucose uptake in rats through an ATP-sensitive K+ channel dependent mechanism.
    Pulido N; Casla A; Suárez A; Casanova B; Arrieta FJ; Rovira A
    Diabetologia; 1996 Jan; 39(1):22-7. PubMed ID: 8720599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response characteristics for glucose-stimulated insulin release in man and assessment of influence of glucose on arginine-stimulated insulin release.
    van Haeften TW; Boonstra E; Veneman TF; Gerich JE; van der Veen EA
    Metabolism; 1990 Dec; 39(12):1292-9. PubMed ID: 2246970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period.
    Thibault C; Guettet C; Laury MC; N'Guyen JM; Tormo MA; Bailbé D; Portha B; Pénicaud L; Ktorza A
    Diabetologia; 1993 Jul; 36(7):589-95. PubMed ID: 8359576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
    Matthews DR; Boland O
    Metabolism; 1997 Dec; 46(12 Suppl 1):5-9. PubMed ID: 9439551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulinotropic effects of hypoglycaemic and hyperglycaemic sulphonamides: the ionophoretic hypothesis.
    Couturier E; Malaisse WJ
    Diabetologia; 1980 Oct; 19(4):335-40. PubMed ID: 6253340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS; Ryan AS; Minaker KL; Elahi D
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modalities of gliclazide-induced Ca2+ influx into the pancreatic B-cell.
    Lebrun P; Malaisse WJ; Herchuelz A
    Diabetes; 1982 Nov; 31(11):1010-5. PubMed ID: 6757009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
    Hosker JP; Burnett MA; Davies EG; Harris EA; Turner RC
    Diabetologia; 1985 Nov; 28(11):809-14. PubMed ID: 3936738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
    Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of extracellular pH upon the ionic and secretory response to gliclazide in pancreatic islets.
    Billaudel B; Mathias PC; Lebrun P; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):139-58. PubMed ID: 6422527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.
    Zhou YP; Grill V
    J Clin Endocrinol Metab; 1995 May; 80(5):1584-90. PubMed ID: 7745004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effects of a calcium-agonist and hypoglycemic or hyperglycemic sulfonamides upon insulin release.
    Malaisse WJ; Sener A; Malaisse-Lagae F
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):71-83. PubMed ID: 3898259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactation-induced changes in calcium handling by rat pancreatic islets.
    Hubinont CJ; Malaisse WJ
    J Dev Physiol; 1987 Feb; 9(1):31-9. PubMed ID: 3549859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect of a tumor-promoting phorbol ester and a hypoglycemic sulfonylurea upon insulin release.
    Malaisse WJ; Lebrun P; Herchuelz A; Sener A; Malaisse-Lagae F
    Endocrinology; 1983 Nov; 113(5):1870-7. PubMed ID: 6354699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of amylin from perfused rat pancreas in response to glucose, arginine, beta-hydroxybutyrate, and gliclazide.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Diabetes; 1991 Aug; 40(8):1005-9. PubMed ID: 1860552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.
    Palmer KJ; Brogden RN
    Drugs; 1993 Jul; 46(1):92-125. PubMed ID: 7691511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-antagonists and islet function. V. Effect of R33711.
    Malaisse WJ; Sener A; Devis G; Somers G
    Horm Metab Res; 1976 Nov; 8(6):434-8. PubMed ID: 793972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
    Hart LM; Dekker JM; van Haeften TW; Ruige JB; Stehouwer CD; Erkelens DW; Heine RJ; Maassen JA
    Diabetologia; 2000 Apr; 43(4):515-9. PubMed ID: 10819247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.